Table 4 Demographic characteristics of the study population and their reported drug uptake in relation to their LF infection status
Characteristic | No. (%) of total | No. (%) with CFA | χ2-value (P-value) | No (%)a with hydrocele | χ2-value (P-value) | No (%) with elephantiasis | χ2-value (P-value) |
|---|---|---|---|---|---|---|---|
Gender (n = 854) | |||||||
 Males | 481 (56.3) | 8 (1.6) | 3.921 (0.048) | 23 (4.8) | – | 18 (3.7) | 2.573 (0.109) |
 Females | 373 (43.7) | 1 (0.3) |  |  |  | 7 ( 1.9) |  |
Age groups in years (n = 854) | |||||||
 ≤ 29 | 450 (52.7) | 4 (0.9) | 0.248 (0.618) | 5 (2.0) | 8.723 (0.003) | 13 (2.9) | 0.005 (0.944) |
 ≥ 30 | 404 (47.3) | 5 (1.2) |  | 18 (7.8) |  | 12 (3.0) |  |
Reported drug uptake in previous MDAs (n = 854) | |||||||
 Yes | 704 (82.4) | 4 (0.6) | 8.723 (0.003) | 9 (2.4) | 22.743 (0.001) | 19 (2.7) | 0.737 (0.391) |
 No | 150 (17.6) | 5 (3.3) |  | 14 (13.7) |  | 6 (4.0) |  |
Reported drug uptake in 2014 MDA (n = 854) | |||||||
 Yes | 603 (70.6) | 6 (1.0) | 0.068 (0.794) | 8 (2.5) | 10.243 (0.001) | 16 (2.7) | 0.542 (0.462) |
 No | 251 (29.4) | 3 (1.2) |  | 15 (9.1) |  | 9 (3.6) |  |